Endotoxin testing milestone reached with European Pharmacopoeia’s animal shift
The quality control (QC) standards publication sets animal-free bacterial endotoxins testing (BET) as the new norm in Europe.
List view / Grid view
The quality control (QC) standards publication sets animal-free bacterial endotoxins testing (BET) as the new norm in Europe.
27 March 2012 | By College Hill
Activiomics Limited., the developer of innovative biomarker technologies has announced the appointment of industry leader Dr Trevor Nicholls to its Board as Non-Executive Chairman.
26 March 2012 | By AstraZeneca
The US District Court for the District of Columbia issued an opinion and order in AstraZeneca’s lawsuit...
26 March 2012 | By Sanofi
Data from two Phase 2 trials announced...
26 March 2012 | By Teva Pharmaceutical Industries Ltd
New treatment with “dry” mode of delivery seeks to address unmet needs of seasonal and perennial allergy sufferers...
25 March 2012 | By Amgen
Robust AMG 145 Phase 2 program expected to deliver results in 2012...
24 March 2012 | By Merck
Results from TRA-2P study - published...
23 March 2012 | By GlaxoSmithKline
COPD and asthma regulatory plans remain on track for submission from mid-2012...
23 March 2012 | By Amylin Pharmaceuticals, Inc.
Patients in pivotal study achieved better glycemic control overall and after meals...
22 March 2012 | By Catalent Pharma Solutions
Catalent Pharma Solutions announces the completion of new Development and Analytical Solutions’ laboratories at its facility in Swindon, UK.
22 March 2012 | By AstraZeneca
The High Court in the UK has rendered its opinion on the formulation patent protecting SEROQUEL XR®...
22 March 2012 | By GlaxoSmithKline
Up to 1,000 new jobs created...
21 March 2012 | By Lundbeck
Lundbeck has appointed Jacob Tolstrup as new vice president with responsibility for the company's business development...
21 March 2012 | By Abbott
AbbVie the new, independent research-based pharmaceutical company...
Freddy White, European Pharmaceutical Review speaks to Marketing Director for Informatics at Thermo Fisher Scientific, Susan Najjar...
20 March 2012 | By Merck
"Merck remains confident in the potential of the investigational agent ridaforolimus..."